Skip to main content

USPTO Publishes One Patent, Five Patent Applications Related to RNAi: Feb 8, 2007

Premium
Title: Inhibition of Syk Kinase Expression
 
Number: 7,173,015
 
Filed: July 1, 2004
 
Lead Inventor: Alan Schreiber, University of Pennsylvania (ZaBeCor)
 
The invention “relates, in general, to Syk kinase and, in particular, to a method of inhibiting Syk kinase expression using small interfering RNA,” according to the patent’s abstract.
 

 
Title: Gene Therapy of HBV Infection Via Adeno-Associated Viral Vector-Mediated Long-Term Expression of Small Hairpin RNA
 
Number: 20070027099
 
Filed: June 12, 2006
 
Lead Inventor: Marie Lin, Nanfang Medical University
 
“The invention provides a vector comprising an AAV-shRNA vector,” the patent application’s abstract states. “The vector is preferably rAAV-151i/1694i. The invention also provides a method of suppressing or inhibiting HBV replication in liver cells infected therewith, comprising administering an amount of an AAVB-shRNA vector effective to suppress, inhibit, or reduce HBV replication.”
 

 
Title: Small Interfering RNA with Improved Activity
 
Number: 20070027097
 
Filed: July 28, 2005
 
Inventor: David Lewis, Mirus
 
The patent application, its abstract states, covers “chemically modified small interfering RNAs. …Combinations of 2'-hydroxyl substitutions on the nucleotide riboses are shown to increase the longevity and extent of target gene knockdown in mammalian cells.”
 

 
Title: Method and System for Identifying microRNA Targets and Synthesizing Novel microRNAs and Uses of the Same
 
Number: 20070026403
 
Filed: July 15, 2004 PCT Filed: July 15, 2004
 
Lead Inventor: Artemis Hatzigeorgiou, University of Pennsylvania
 
The patent application, its abstract states, covers “method of identifying a microRNA-recognition element and of generating microRNAs. … System and computer programs for performing such methods are disclosed [in the application also, as are] … recombinant nucleic acid molecule comprising a heterologous coding sequences and one or more MREs,”
The application further claims “isolated nucleic acid molecule comprising one or more MRE sequences and being free of a coding sequence operably linked to regulatory elements,” the abstract states. “MicroRNA generated by methods of the invention and the use of the microRNAs to downregulate gene expression are [also] disclosed.”
 

 
Title: Modulation of Gene Expression Associated with Inflammation Proliferation and Neurite Outgrowth Using Nucleic Acid-Based Technologies
 
Number: 20070026394
 
Filed: April, 3 2002 PCT Filed: April 3, 2002
 
Lead Inventor: Lawrence Blatt, Sirna Therapeutics (Merck)
 
The invention relates to “nucleic acid molecules, including antisense, enzymatic nucleic acid molecules, and RNA interference molecules … which modulate the expression of prostaglandin D2 (PTGDS), prostaglandin D2 receptor (PTGDR), adenosine receptor, NOGO and NOGO receptor, and IKK genes, such as IKK-gamma, IKK-alpha, or IKK-beta, and PKR genes,” the patent application’s abstract states.
 

 
Title: RNAi Expression Constructs
 
Number: 20070025969
 
Filed: Feb. 3, 2006
 
Lead Inventor: Petrus Roelvink, Benitec
 
The invention “provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues, or organs of interest in vitro and in vivo so as to treat diseases or disorders,” according to the patent application’s abstract.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.